4wvo
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | |||
==An engineered PYR1 mandipropamid receptor in complex with mandipropamid and HAB1== | ==An engineered PYR1 mandipropamid receptor in complex with mandipropamid and HAB1== | ||
<StructureSection load='4wvo' size='340' side='right' caption='[[4wvo]], [[Resolution|resolution]] 2.25Å' scene=''> | <StructureSection load='4wvo' size='340' side='right' caption='[[4wvo]], [[Resolution|resolution]] 2.25Å' scene=''> | ||
| Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=3UZ:(2S)-2-(4-CHLOROPHENYL)-N-{2-[3-METHOXY-4-(PROP-2-YN-1-YLOXY)PHENYL]ETHYL}-2-(PROP-2-YN-1-YLOXY)ETHANAMIDE'>3UZ</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=3UZ:(2S)-2-(4-CHLOROPHENYL)-N-{2-[3-METHOXY-4-(PROP-2-YN-1-YLOXY)PHENYL]ETHYL}-2-(PROP-2-YN-1-YLOXY)ETHANAMIDE'>3UZ</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Phosphoprotein_phosphatase Phosphoprotein phosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.3.16 3.1.3.16] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Phosphoprotein_phosphatase Phosphoprotein phosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.3.16 3.1.3.16] </span></td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4wvo FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4wvo OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4wvo RCSB], [http://www.ebi.ac.uk/pdbsum/4wvo PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4wvo FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4wvo OCA], [http://pdbe.org/4wvo PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4wvo RCSB], [http://www.ebi.ac.uk/pdbsum/4wvo PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4wvo ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| Line 17: | Line 18: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 4wvo" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 18:42, 1 February 2017
An engineered PYR1 mandipropamid receptor in complex with mandipropamid and HAB1
| |||||||||||
